TERN

Terns Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$52.72

Market Cap

$4.75B

Beta

-0.38

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+8.85%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.73%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for TERN.